These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 708293)

  • 1. Hemostatic changes induced in vitro by hemoperfusion over activated charcoal.
    Winchester JF; MacKay JM; Forbes CD; Courtney JM; Gilchrist T; Prentice CR
    Artif Organs; 1978 Aug; 2(3):293-300. PubMed ID: 708293
    [No Abstract]   [Full Text] [Related]  

  • 2. Hemoperfusion leads to impairment in hemostasis and coagulation process in patients with acute pesticide intoxication.
    Park S; Islam MI; Jeong JH; Cho NJ; Song HY; Lee EY; Gil HW
    Sci Rep; 2019 Sep; 9(1):13325. PubMed ID: 31527808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of hemoperfusion with coated and uncoated charcoal on human blood in vitro.
    Ott NT; Kohnle W; Scheck R; Konstantin P; Franz HE
    J Dial; 1979; 3(4):291-308. PubMed ID: 263952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymer coating for hemoperfusion over activated charcoal.
    Hasirci N; Akovali G
    J Biomed Mater Res; 1986 Sep; 20(7):963-70. PubMed ID: 3760012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of a charcoal sorbent fiber with commercial charcoals for hemoperfusion.
    Gundermann KJ; Uhlhaas S; Grünn U; Olek K; Ukigusa M; Lie TS
    Artif Organs; 1983 May; 7(2):186-96. PubMed ID: 6870596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acid citrate dextrose reduces platelet retention during in vitro and in vivo dog hemoperfusion: a comparative study of different charcoal adsorbers.
    Tangerman A; Snel P; van Schaik A; van Tongeren JH
    Artif Organs; 1981 Nov; 5(4):357-62. PubMed ID: 7325877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term hemoperfusion with coated activated charcoal.
    Mamdani B; Dunea G; Siemsen AW
    Clin Toxicol; 1980 Nov; 17(4):543-6. PubMed ID: 7460506
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro adsorption spectrum of plasma amino acids by coated charcoal hemoperfusion.
    Shi ZQ; Chang TM
    Int J Artif Organs; 1983 Sep; 6(5):267-70. PubMed ID: 6642724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clearance of meprobamate by hemoperfusion over columns of charcoal and Amberlite resin. Studies in a patient.
    Hoy W; Schwab G; Freeman RB
    Artif Organs; 1978 Nov; 2(4):395-7. PubMed ID: 743013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ACAC (albumin-collodion coated activated charcoal) hemoperfusion: in-vitro removal and clearance of theophylline.
    Espinosa-Meléndez E; Chang TM
    J Dial; 1980; 4(1):21-9. PubMed ID: 7410675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet function in fulminant hepatic failure and effect of charcoal haemoperfusion.
    Weston MJ; Langley PG; Rubin MH; Hanid MA; Mellon P; Williams R
    Gut; 1977 Nov; 18(11):897-902. PubMed ID: 590850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of hemoperfusion of cross-linked agarose coated activated charcoal (CAAC-II) on T-lymphocyte function in rats and guinea pigs.
    Li F; Shu CD; Li ZM
    Biomater Artif Cells Artif Organs; 1987; 15(1):215-28. PubMed ID: 3502391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cytochemical changes and the adherence of neutrophil during cross-linked agarose encapsulated activated charcoal hemoperfusion.
    Chen GX; Shu CD; He J
    Biomater Artif Cells Immobilization Biotechnol; 1991; 19(1):277-81. PubMed ID: 1661186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bile acid clearance and biocompatibility of XAD-4 haemoperfusion.
    Bolhuis PA; Sinaasappel M
    Int J Artif Organs; 1978 May; 1(3):135-41. PubMed ID: 689756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical experience with charcoal and resin hemoperfusion.
    Hughes R; Williams R
    Semin Liver Dis; 1986 May; 6(2):164-73. PubMed ID: 3018936
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of charcoal hemoperfusion with prostacyclin on the coagulation-fibrinolysis system and platelets of patients with fulminant hepatic failure--preliminary observations.
    Cordopatri F; Boncinelli S; Marsili M; Lorenzi P; Fabbri LP; Paci P; Salvadori M; Morfini M; Cinotti S; Casparini P
    Int J Artif Organs; 1982 Jul; 5(4):243-7. PubMed ID: 6749697
    [No Abstract]   [Full Text] [Related]  

  • 17. Regular hemoperfusion in regular dialysis treatment. A long-term study.
    Stefoni S; Colì L; Feliciangeli G; Baldrati L; Bonomini V
    Int J Artif Organs; 1980 Nov; 3(6):348-53. PubMed ID: 7461873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro assessment of the hemocompatible properties of polymers.
    Sevastianov VI; Belomestnaia ZM; Zimin NK
    Artif Organs; 1983 Feb; 7(1):126-33. PubMed ID: 6838401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noncardiogenic pulmonary edema after charcoal hemoperfusion.
    Engstrom JW; Young J; Rennie WA; Kennedy TP
    South Med J; 1985 May; 78(5):611-3. PubMed ID: 3992308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe coagulopathy complicating charcoal hemoperfusion in children with Reye syndrome.
    Engle WD; Jacobs JF; Swartz RD; Duff TE; Kelsch RC; Lane GA; Baublis JV
    J Pediatr; 1978 Dec; 93(6):972-4. PubMed ID: 722443
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.